Iron supplement

18 marketed 4 in Phase 3 2 in Phase 2

This page covers all Iron supplement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Iron (Fe2+/Fe3+), Iron (Fe2+) for hemoglobin and myoglobin synthesis, Iron (Fe2+/Fe3+) — cofactor for hemoglobin and myoglobin synthesis.

Targets

Iron (Fe2+/Fe3+) · Iron (Fe2+) for hemoglobin and myoglobin synthesis · Iron (Fe2+/Fe3+) — cofactor for hemoglobin and myoglobin synthesis · Iron (Fe2+/Fe3+) for hemoglobin and myoglobin synthesis · Iron (Fe³⁺) delivery via maltol chelation · Iron (Fe2+) for hemoglobin synthesis

Marketed (18)

Phase 3 pipeline (4)

Phase 2 pipeline (2)